ShareThis Page
Respironics merger with Philips delayed again |

Respironics merger with Philips delayed again

| Monday, February 25, 2008 12:00 a.m

Respironics Inc.’s intended acquirer, Royal Philips Electronics of The Netherlands, said today that it extended its tender offer to shareholders once again because the European Union has not signed off on the deal yet.

The company, based in Murrysville, agreed to be acquired by Royal Philips on Jan. 3 for $66 a share. As of Feb. 22, holders of about 82 percent of Respironics stock have tendered their shares — far in excess of the 50-plus percent required.

The tender offer will now expire on March 5, which marks the end of the European Union’s deal-review period. The $5.1 billion deal had initially been expected to close by Jan. 31.

The deal has already received antitrust clearance from U.S. regulators. Respironics makes sleep- and breathing-aid devices.

Respironics stock at mid-day was trading at $65.70 a share, up 11 cents.

Categories: News
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.